scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1047793715 |
P356 | DOI | 10.1038/CR.2010.133 |
P953 | full work available at URL | https://www.nature.com/articles/cr2010133.pdf |
http://www.nature.com/articles/cr2010133.pdf | ||
http://www.nature.com/articles/cr2010133 | ||
P698 | PubMed publication ID | 20838419 |
P5875 | ResearchGate publication ID | 46256345 |
P2093 | author name string | Wei Wang | |
Jie Meng | |||
Xian-Da Yang | |||
Zhao Sun | |||
Haiyan Xu | |||
Shuchang Chen | |||
P2860 | cites work | Biomedical applications of functionalised carbon nanotubes | Q36020728 |
Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy | Q39948212 | ||
Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine | Q44703236 | ||
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma | Q44980797 | ||
A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes. | Q53661005 | ||
A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines | Q33289806 | ||
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial | Q33920539 | ||
Progress in human tumour immunology and immunotherapy | Q34253585 | ||
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial | Q34491558 | ||
Dendritic cells in vaccination therapies of malignant diseases | Q34913813 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
carbon nanotube | Q1778729 | ||
P1104 | number of pages | 4 | |
P304 | page(s) | 1170-1173 | |
P577 | publication date | 2010-09-14 | |
P1433 | published in | Cell Research | Q1524018 |
P1476 | title | Multi-walled carbon nanotubes conjugated to tumor protein enhance the uptake of tumor antigens by human dendritic cells in vitro | |
P478 | volume | 20 |
Q28389641 | Carbon nanotubes enhance cytotoxicity mediated by human lymphocytes in vitro |
Q28388765 | Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivo |
Q64056591 | Cellular Toxicity and Immunological Effects of Carbon-based Nanomaterials |
Q37195052 | Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy |
Q57132240 | Enhanced protective immunity against spring viremia of carp virus infection can be induced by recombinant subunit vaccine conjugated to single-walled carbon nanotubes |
Q28389458 | In vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxide |
Q57492118 | Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy |
Q28390421 | Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFκB activation and reduces its immunotoxicity |
Q92255186 | Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment |
Q55004711 | Utilizing the nanosecond pulse technique to improve antigen intracellular delivery and presentation to treat tongue squamous cell carcinoma. |
Search more.